EMT, CTCs and CSCs in tumor relapse and drug-resistance
Abhisek Mitra(The University of Texas MD Anderson Cancer Center), Shulin Li(The University of Texas MD Anderson Cancer Center)
Cited by 464
Related Papers
Potential role of nuclear PD-L1 expression in cell-surface vimentin positive circulating tumor cells as a prognostic marker in cancer patients
|Scientific Reports|2016|195
FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation
|Nature Communications|2019|119
WSX1 act as a tumor suppressor in hepatocellular carcinoma by downregulating neoplastic PD-L1 expression
|Nature Communications|2021|56
Immune checkpoint regulator PD-L1 expression on tumor cells by contacting CD11b positive bone marrow derived stromal cells
|Cell Communication and Signaling|2015|54